AI assistant
BRUNNER INV TST PLC — Director's Dealing 2020
Apr 22, 2020
5135_dirs_2020-04-22_bbe2c3dc-fb34-4d36-ba56-a9f4e2c6dbc0.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
RNS Number : 5607K
Brunner Investment Trust PLC
22 April 2020
The Brunner Investment Trust PLC
LEI - 529900S0Y9ZINCHB3O93
The interest of Andrew Hutton, a person discharging managerial responsibilities, in the ordinary shares of The Brunner Investment Trust PLC is notified as below:
| Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons associated with them | ||||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||
| a) | Name | Andrew Hutton | ||
| 2 | Reason for the notification | |||
| a) | Position/status | Director | ||
| b) | Initial notification /Amendment | Interests held on appointment | ||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||
| a) | Name | The Brunner Investment Trust PLC | ||
| b) | LEI | 529900S0Y9ZINCHB3O93 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted. | |||
| a) | Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of 25 pence each GB0001490001 |
||
| b) | Nature of the transaction | Interests held on appointment | ||
| c) | Price(s) and volume(s) | Prices(s) N/A |
Volume(s) 6,000 |
|
| d) | Aggregated information | N/A | ||
| - Aggregated volume - Price |
||||
| e) | Date of the transaction | N/A | ||
| f) | Place of the transaction | N/A | ||
Kirsten Salt
Company Secretary
020 3246 7513
22 April 2020
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHFLFIRSTIFFII